Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Rapid Biologics Development to Maximize your Speed to Clinic

Product Image
Product Description

Whether you are using a Catalent GPEx® technology-based cell line or a client-derived cell line, we can design a process for your project that can be easily transferred to our production plant. All operations from cell line development through production of preclinical and/or clinical (Phase I/II) API can be performed in a single facility with a dedicated project manager – thus ensuring better continuity and reliability. Backed by experts in the fields of molecular biology, cell line development, process development, biopharmaceutical manufacturing, and quality systems, we are able to streamline processes, and enhance performance, and speed through to clinical production.

Catalent Services

• Generation of master and working cell banks
• Cell line stability studies
• Upstream process development in shake flask and bioreactor systems (2L - 10L)
• Downstream process development at the milligram to 100s gram scale
• Scale down and non-cGMP production (up to 100L) in disposable and stainless bioreactors
• cGMP manufacturing of Phase I / Phase II material in product-dedicated suites using stirred tank bioreactors at the 200L scale

Product Rapid Biologics Development to Maximize your Speed to Clinic
Company Catalent Pharma Solutions
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Catalent Pharma Solutions
Sedge Close, Headway, Great Oakley Corby, Northamptonshire NN18 8HS, England

Tel: 44 (0) 1536 461146
Fax: 44 (0) 1536 461011
Email: info@catalent.com



Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!